Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:05 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 302 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cerebellar Disorders Clear all

Conditions: Brain and Central Nervous System Tumors
Interventions: semaxanib; Drug
Lead sponsor: Pediatric Brain Tumor Consortium; Network
Eligibility: Up to 21 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 9
States / cities: San Francisco, California • Washington D.C., District of Columbia • Boston, Massachusetts + 6 more

Conditions: Spinocerebellar Ataxia Type 3
Interventions: Specimen Collection; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Friedreich's Ataxia
Interventions: EPI-743; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Brain Tumor, Central Nervous System Tumor
Interventions: carboplatin, temozolomide, vincristine sulfate; Drug
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 10 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ataxia Telangiectasia
Interventions: Antisense oligonucleotide targeting the ATM gene; Drug
Lead sponsor: Timothy Yu; Other
Eligibility: 0 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Brain and Central Nervous System Tumors, Leukemia, Lymphoma, Metabolic Syndrome, Sarcoma
Interventions: metabolic assessment, questionnaire administration; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 9 Years to 18 Years
Enrollment: 512 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Brain and Central Nervous System Tumors, Gastrointestinal Stromal Tumor, Sarcoma
Interventions: sargramostim, telomerase: 540-548 peptide vaccine; Biological
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 2 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Trigeminal Nerve Injuries, Post-herpetic Neuralgia, Facial Pain, Nervus Intermedius Neuralgia
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 110 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cerebellar Ataxia
Interventions: Home exercise program; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 95 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Ataxia, Spino Cerebellar Degeneration, Spinocerebellar Ataxias
Interventions: Aerobic training, Balance Training; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Cerebellar Disease, Dementia, Healthy, Parkinson's Disease
Interventions: Cadwell Rapid Rate Magnetic Stimulator; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Brain and Central Nervous System Tumors
Interventions: cisplatin, etoposide, ifosfamide, lomustine, methotrexate, prednisone, vincristine sulfate; Drug
Lead sponsor: German Society for Pediatric Oncology and Hematology GPOH gGmbH; Other
Eligibility: 3 Years to 18 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson's Disease
Interventions: Not listed
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Spinocerebellar Ataxias
Interventions: BHV-4157; Drug
Lead sponsor: Biohaven Therapeutics Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 909 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Dystonia, Focal Dystonia, Cerebellar Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 85 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alcohol Use Disorder
Interventions: Repetitive transcranial magnetic stimulation (rTMS), Sham transcranial magnetic stimulation; Device
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Friedreich's Ataxia
Interventions: Low dose cohort, High dose cohort; Drug
Lead sponsor: Biojiva LLC; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Long Beach, California • Tampa, Florida

Conditions: Spinocerebellar Ataxia
Interventions: Not listed
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Jackson, Mississippi • Galveston, Texas

Conditions: Friedreich Ataxia
Interventions: Interferon Gamma-1b; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 5 Years to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia 3
Interventions: Not listed
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder I
Interventions: Excitatory TMS, Inhibitory TMS, Sham TMS; Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Belmont, Massachusetts • Charlestown, Massachusetts

Conditions: Autism, Autism Spectrum Disorder
Interventions: Transcranial direct current stimulation; Device
Lead sponsor: American University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Advanced Solid Tumors
Interventions: Elimusertib (BAY1895344), Pembrolizumab (Keytruda®); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 8
States / cities: Palo Alto, California • New Haven, Connecticut • Baltimore, Maryland + 5 more

Conditions: Spinocerebellar Ataxia
Interventions: Error-reduction, International Cooperative Ataxia Rating Scale, Scale for the Assessment and Rating of Ataxia, Beck Depression Inventory, 2nd Ed, Stroop, Purdue Pegboard, Brief Test of Attention, 6-minute Walk, Hand Grip Dynamometer, Montreal Cognitive Assessment, Physical Performance Function, Biomechanical Assessments of Dysmetria, Neurophysiological assessment of brain activity, Biomechanical gait analysis; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 85 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Identification of Biomarkers in Spinocerebellar Ataxia 3

EPI-743 in Friedreich's Ataxia Point Mutations

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)

Metabolic Syndrome in Childhood Cancer Survivors

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Transcranial Magnetic Stimulation for Facial Pain

Exercise Training Program for Cerebellar Ataxia

Aerobic Exercise, Balance Training, and Ataxia

Effects of Brain Stimulation on Learning and Reasoning

Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas

The Role of Cerebellar Hyperactivity in Parkinson's Disease

Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control

Brain Changes in Blepharospasm

Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder

A First in Human Study of RT001 in Patients With Friedreich's Ataxia

Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias

Interferon Gamma-1b in Friedreich Ataxia (FRDA)

Clinical Trial Readiness for SCA1 and SCA3

Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study

Cerebellum and Autism: Regional Specialization for Social and Executive Functions

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia